CELEX: 62010CA0011
Language: en
Date: 2011-02-17 00:00:00
Title: Case C-11/10: Judgment of the Court (Fifth Chamber) of 17 February 2011 (reference for a preliminary ruling from the Hoge Raad der Nederlanden (Netherlands)) — Staatssecretaris van Financiën v Marishipping and Transport BV (Reference for a preliminary ruling — Regulation (EEC) No 2658/87 — Common Customs Tariff — Customs duties — Relief — Pharmaceutical substances — Composition — Restrictions)

2.4.2011   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 103/7
            
         Judgment of the Court (Fifth Chamber) of 17 February 2011 (reference for a preliminary ruling from the Hoge Raad der Nederlanden (Netherlands)) — Staatssecretaris van Financiën v Marishipping and Transport BV
   (Case C-11/10) (1)
   
   (Reference for a preliminary ruling - Regulation (EEC) No 2658/87 - Common Customs Tariff - Customs duties - Relief - Pharmaceutical substances - Composition - Restrictions)
   2011/C 103/10
   Language of the case: Dutch
   
      Referring court
   
   Hoge Raad der Nederlanden
   
      Parties to the main proceedings
   
   
      Applicant: Staatssecretaris van Financiën
   
      Defendant: Marishipping and Transport BV
   
      Re:
   
   Reference for a preliminary ruling from the Hoge Raad der Nederlanden (Netherlands) — Interpretation of Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (OJ 1987 L 256, p. 1) — Pharmaceutical substances exempted from customs duties — Substance not presented in its pure form — Restrictions
   
      Operative part of the judgment
   
   Part One, Section II, C, 1(i) of Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff, as amended by Commission Regulations (EC) Nos 2031/2001 of 6 August 2001 and 1832/2002 of 1 August 2002, must be interpreted as meaning that a pharmaceutical substance listed in Annex 3 of Part Three of Annex I, to which other substances have been added, in particular pharmaceutical substances, no longer qualifies for the duty-free treatment which would have applied if such a substance had been in its pure form.
   
      (1)  OJ C 80, 27.3.2010.